All In MedTech

Device Trial Radar · NCT06292494

Focused Ultrasound for Drug-resistant Epilepsy

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Jan 1, 2024

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Taipei Veterans General Hospital, TaiwanGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
InSightec
First posted
Mar 5, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Focused ultrasound (FUS) has been shown to differentially lesion or modulate (excite and inhibit) brain circuit and neural activity across a broad range of acoustic stimulus parameters (intensity, duty cycle, pulse repetition frequency and pulse duration) for decades. From our previous study, FUS sonication may suppress the number of epileptic signal bursts observed in EEG recordings after the induction of acute epilepsy. The presence of the suppressive effect was found in terms of the number of epileptic EEG spikes from the analysis of the unfiltered and theta-band EEG activity, and further discontinue the seizure attacks. EEG activity has also been consistently reported to have a positive correlation with the level of epilepsy, and FUS-mediated reduction of epileptic EEG activity was most notably observed, no matter lesioning or modulating effects. The aims of this study are to demonstrate the safety and efficacy of FUS technology in epilepsy patients and to estimate the optimal parameters of focused ultrasound exposure that will be used in the case of epilepsy.

Conditions

  • Focused Ultrasound
  • MR-guided FUS
  • Drug Refractory Epilepsy
  • Drug Resistant Epilepsy
  • Medication Resistant Epilepsy

Interventions

  • Exablate 4000 Transcranial MRgfUS SystemDevice

    Focused ultrasound interrupt structure of epilepsy network to improve seizure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. pulse rate [Safety]Time frame: pre- and post- treatment immediately
  2. blood oxygen saturation level [Safety]Time frame: pre- and post- treatment immediately
  3. MRI [Safety]Time frame: pre- and post- treatment immediately

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Taipei Veterans General Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.